Hatteras’ mission is to build transformational human medicine companies that benefit patients and the professionals who serve them. Over half of our portfolio companies were created with our initial investment.

At Hatteras Venture Partners, we believe that breakthrough science and entrepreneurial innovation have the power to create valuable new ways of treating and diagnosing disease, providing value for our investors and transforming human health.

The Hatteras team brings operational experience, a renowned strategic partner network, and a successful investment track record. We are passionate about utilizing our backgrounds to engage entrepreneurs and enhance the value of their companies.


Latest News

Press Ganey Expands Real-Time Data Collection Capabilities Through Acquisition of Bivarus

January 16, 2018

Dynamic Consumer Feedback Technology Builds Upon Press Ganey’s Leading Digital Platform January 16, 2018 — BOSTON — Press Ganey today announced the acquisition of Bivarus, which offers real-time patient and caregiver insights through…

More News